Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0530
0.00 (0.00%)
Sep 17, 2026, 9:59 AM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 37.12 million as of September 17, 2026. Its market cap has decreased by -27.44% in one year.
Market Cap
37.12M
Enterprise Value
33.28M
Revenue
14.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 37.12M, a decrease of -61.35%. That is a compound annual growth rate of -19.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 37.12M | -19.80% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 521.83M |
| Healius | 330.40M |
| Monash IVF Group | 294.17M |
| Cryosite | 57.60M |
| Rhythm Biosciences | 28.31M |
| BCAL Diagnostics | 26.18M |
| INOVIQ | 23.93M |
| ImExHS | 17.68M |